RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma
Clinical trial NCT01189240 · TERMINATED
Trial details
- NCT number
- NCT01189240
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2013-01-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.